dual gip/glp-1 receptor agonist Tirzepatide's Unique Mechanism of Action Dual GLP-1 / GIP Receptor

More than half of those who have used GLP-1s say they found it difficult to afford the drugs even with insurance, rebates and discount coupons

Global responses to prevent, manage, and control cardiovascular diseases

Nicholls SJ, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, et al

In mice, genetic deletion or pharmacologic inhibition of DPP4 is able to increase the homing of CXCR4+ EPC at sites of myocardial damage, resulting in a reduced cardiac remodeling and improved heart function and survival (200)

Treat it as a supporting compound in a broader metabolic stack rather than a primary intervention

The selected studies were published between 2015 and 2019